Marjorie Shapiro

Dr. Marjorie Shapiro received her Ph.D. in immunology from the University of Pennsylvania where she studied molecular mechanisms underlying antibody diversity. She has been at the FDA for over 30 years and is known for her expertise in therapeutic monoclonal antibodies and related products such as antibody-drug conjugates, bispecific antibodies, antibody cocktails, Fc-fusion proteins and biosimilar mAbs. She participated in the reviews of the marketing applications for Mylotarg (both the NDA and the BLA), Adcetris, and Trodelvy.

Appearances

This speaker has made no appearances.